Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells

被引:20
|
作者
Demirci, Selami [1 ,2 ]
Dogan, Aysegul [1 ,3 ]
Apdik, Huseyin [1 ]
Tuysuz, Emre Can [1 ,4 ]
Gulluoglu, Sukru [1 ,4 ]
Bayrak, Omer Faruk [4 ]
Sahin, Fikrettin [1 ]
机构
[1] Yeditepe Univ, Fac Engn & Architecture, Dept Genet & Bioengn, Kayisdagi Cad 26 Agustos Yerlesimi, TR-34755 Istanbul, Turkey
[2] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, CDBL, NIH, Frederick, MD 21701 USA
[4] Yeditepe Univ, Sch Med, Dept Med Genet, Inonu Mah,Kayisdagi Cad 26 Agustos Yerlesimi, TR-34755 Istanbul, Turkey
关键词
Cytoglobin; Cell migration; Wound healing; Microarray; Tumor suppressor; STEM-CELLS; CANCER; EXPRESSION; DIFFERENTIATION; PROLIFERATION; ACTIVATION; INVASION; PARTNER; GENE; KPTN;
D O I
10.1007/s11010-017-3101-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cell proliferation and migration are crucial in many physiological processes including development, cancer, tissue repair, and wound healing. Cell migration is regulated by several signaling molecules. Identification of genes related to cell migration is required to understand molecular mechanism of non-healing chronic wounds which is a major concern in clinics. In the current study, the role of cytoglobin (CYGB) gene in fA +/- broblast cell migration and proliferation was described. L929 mouse fibroblast cells were transduced with lentiviral particles for CYGB and GFP, and analyzed for cell proliferation and migration ability. Fibroblast cells overexpressing CYGB displayed decreased cell proliferation, colony formation capacity, and cell migration. Phosphorylation levels of mTOR and two downstream effectors S6 and 4E-BP1 which take part in PI3K/AKT/mTOR signaling declined in CYGB-overexpressing cells. Microarray analysis indicated that CYGB overexpression leads to downregulation of cell proliferation, migration, and tumor growth associated genes in L929 cell line. This study demonstrated the role of CYGB in fibroblast cell motility and proliferation. CYGB could be a promising candidate for further studies as a potential target for diseases related to cell migration such as cancer and chronic wound treatment.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 50 条
  • [1] Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells
    Selami Demirci
    Ayşegül Doğan
    Hüseyin Apdik
    Emre Can Tuysuz
    Sukru Gulluoglu
    Omer Faruk Bayrak
    Fikrettin Şahin
    Molecular and Cellular Biochemistry, 2018, 437 : 133 - 142
  • [2] Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway
    Hu, Binwu
    Lv, Xiao
    Gao, Feng
    Chen, Songfeng
    Wang, Shangyu
    Qing, Xiangcheng
    Liu, Jianxiang
    Wang, Baichuan
    Shao, Zengwu
    ONCOTARGETS AND THERAPY, 2017, 10 : 4379 - 4391
  • [3] Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway
    Wu, Chunyu
    Qiu, Shengliang
    Liu, Pei
    Ge, Yuqing
    Gao, Xiufei
    JOURNAL OF ETHNOPHARMACOLOGY, 2018, 211 : 89 - 100
  • [4] Arnicolide D Inhibits Proliferation and Induces Apoptosis of Osteosarcoma Cells through PI3K/Akt/mTOR Pathway
    Chen, Zhuo
    Ni, Renhua
    Hu, Yuanyu
    Yang, Yiyuan
    Tian, Yun
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2024,
  • [5] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [6] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [7] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [8] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [9] Sanguinarine inhibits melanoma invasion and migration by targeting the FAK/PI3K/AKT/mTOR signalling pathway
    Qi, Xiaoyi
    Chen, Yonglan
    Liu, Sha
    Liu, Li
    Yu, Zehui
    Yin, Ling
    Fu, Lu
    Deng, Mingming
    Liang, Sicheng
    Lu, Muhan
    PHARMACEUTICAL BIOLOGY, 2023, 61 (01) : 696 - 709
  • [10] HRK inhibits colorectal cancer cells proliferation by suppressing the PI3K/AKT/mTOR pathway
    Wang, Haowei
    Chen, Yujia
    Yuan, Qinzi
    Chen, Lixia
    Dai, Peiling
    Li, Xuenong
    FRONTIERS IN ONCOLOGY, 2022, 12